
Amplía el crédito en dólares al 15% para empresas
El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.

The official dollar price rises to $1515 and the blue dollar is quoted at $1540. The Argentine financial market is affected by these changes in the dollar quotation.
The official dollar repented to $1515 for sale at the Banco Nación, while the blue dollar advanced to $1540 for the same operation.
The official dollar and blue dollar quotation is a topic of interest for investors and operators in the Argentine financial market, as it can influence investment decision-making and the economy in general.
The blue dollar quotation, which is the dollar price in the parallel market, can be an indicator of investor confidence in the Argentine economy and the local currency.
Among the factors influencing the dollar quotation are the supply and demand of currencies, the government's monetary and fiscal policy, and international economic and political events.
The official dollar quotation, on the other hand, is influenced by the Central Bank's intervention in the foreign exchange market, which seeks to maintain exchange rate stability and prevent capital flight.
The increase in the dollar quotation can have a negative impact on the Argentine economy, as it can increase inflation and reduce the competitiveness of exports.
However, it can also have a positive impact on investors who have assets in foreign currency, as they can obtain higher returns on their investment.
In the next 30 days, it is expected that the dollar quotation will continue to be volatile, which can generate investment opportunities for operators who are willing to take risks.

El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.

La acción de Moderna subió 95 % después de que su vacuna de ARN mensajero contra el cáncer, desarrollada con Merck, obtuviera el primer resultado positivo en una fase 3.

El pronóstico más audaz de Wall Street sitúa al S&P 500 en 9.000 para fin de 2027, un 17 % por encima del nivel actual.